Chronic heart failure with preserved ejection fraction: optimal therapy. Literature review

Heart Failure With Preserved Ejection Fraction

The Journal of the American Osteopathic Association July 2015 | Vol 115 | No. 7 432 From Henry Ford Wyandotte Downriver Cardiology in Brownstown, Michigan (Dr Rogers); West Suburban Medical Center in Oak Park, Illinois (Dr Gundala); Oakwood Southshore Medical Center in Trenton, Michigan (Dr Ramos); and Elmhurst Memorial Hospital in Illinois (Dr Serajian). Drs Gundala and Ramos are in their thir...

Heart Failure With Preserved Ejection Fraction

Symptomatic heart failure, despite preserved left ventricular (LV) ejection fraction, is a well-recognized phenomenon. This manifestation of diastolic dysfunction is associated with increased morbidity and mortality and can be attributed to a variety of pathogeneses, including diabetes mellitus, hypertension, infiltrative processes, and obesity. Unlike in systolic heart failure, where LV ejecti...

Cell Therapy for Heart Failure With Preserved Ejection Fraction∗

SEE PAGE 14 O ne-half of patients with heart failure (HF) have a preserved ejection fraction (HFpEF), and there is no proven effective treatment (1). The traditional thinking has been that left ventricular (LV) diastolic dysfunction caused by hypertensive ventricular remodeling causes the clinical syndrome of HFpEF. More recent data suggest that it is not so simple, and that other systemic proc...

[Heart failure with preserved ejection fraction (HFpEF)].

Heart Failure with Preserved Ejection Fraction

1. Demonstrate the association between heart failure with preserved ejection fraction (HFpEF) and survival. 2. Given a patient with heart failure (HF), recognize HFpEF on the basis of clinical signs and symptoms, physical examination, echocardiography, and radiographic findings. 3. Classify patients at high risk of hospitalization and mortality through assessing risk factors, clinical presentat...